Dopaminergic degeneration and perfusional impairment in Lewy body dementia and Alzheimer’s disease

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Neurological Sciences

• Publication date

  2003-10-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1007/s10072-003-0110-6PMID 14598067
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Differentiation of dementia with Lewy bodies from Alzheimer's disease using a dopaminergic presynaptic ligand

  2002cited by this paper
• Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD

  2001cited by this paper
• Motor correlates of occipital glucose hypometabolism in Parkinson’s disease without dementia

  1999cited by this paper
• Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution.

  1999cited by this paper
• Parieto-occipital glucose hypometabolism in Parkinson's disease with autonomic failure.

  1999cited by this paper
• Brain perfusion scintigraphy with99mTc-HMPAO or99mTc-ECD and123I-β-CIT single-photon emission tomography in dementia of the Alzheimer-type and diffuse Lewy body disease

  1997cited by this paper
• Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB)

  1996cited by this paper
• Visual hemineglect induced by unilateral striatal dopamine deficiency in monkeys.

  1995cited by this paper
• Clinical diagnosis of Alzheimer's disease

  1984influential reference

• DaTSCAN® dilution with 0.9% NaCl - A stability evaluation.

  2023cites this paper
• The diagnostic performance of functional dopaminergic scintigraphic imaging in the diagnosis of dementia with Lewy bodies: an updated systematic review

  2023cites this paper
• The Effect of Human Umbilical Cord Mesenchymal Stromal Cells in Protection of Dopaminergic Neurons from Apoptosis by Reducing Oxidative Stress in the Early Stage of a 6-OHDA-Induced Parkinson’s Disease Model

  2019cites this paper
• Neuropathological Changes in Dementia With Lewy Bodies and the Cingulate Island Sign

  2019cites this paper
• Apolipoprotein E polymorphism and hippocampal atrophy across the spectrum of Alzheimer’s disease and dementia with Lewy bodies

  2018cites this paper
• Biomarkers of Alzheimer’s Disease

  2017cites this paper
• Clinical validity of presynaptic dopaminergic imaging with 123I-ioflupane and noradrenergic imaging with 123I-MIBG in the differential diagnosis between Alzheimer's disease and dementia with Lewy bodies in the context of a structured 5-phase development framework.

  2017cites this paper
• Assessment of the visual thalamic circuitry in hallucinations in dementia with Lewy bodies

  2017cites this paper
• Single-photon emission computed tomography in the differential diagnosis of dementia with Lewy Bodies

  2015cites this paper
• Transplantation of human mesenchymal stem cells into the cisterna magna and its neuroprotective effects in a parkinsonian animal model

  2015cites this paper
• Dopamine transporter imaging for the diagnosis of dementia with Lewy bodies.

  2015cites this paper
• Clinical presentation and differential diagnosis of dementia with Lewy bodies: a review

  2014cites this paper
• SPECT/PET Findings in Lewy Body Dementia

  2014cites this paper
• Utility of 123I-FP-CIT SPECT for dementia diagnoses and therapeutic strategies in elderly patients

  2013cites this paper
• Alzheimer's disease biomarkers: correspondence between human studies and animal models.

  2013cites this paper
• Biomarkers in dementia with Lewy bodies: a review

  2012cites this paper
• [123I]N‐ω‐fluoropropyl‐2β‐carbomethoxy‐3β‐(4‐iodophenyl)nortropane single‐photon emission computed tomography brain imaging in the diagnosis of dementia with Lewy bodies

  2012cites this paper
• Verbal and Nonverbal Learning and Recall in Dementia with Lewy Bodies and Alzheimer's Disease

  2012cites this paper
• Dopaminergic imaging: clinical utility now and in the future

  2011influential citation
• Therapeutic Efficacy of Intranasally Delivered Mesenchymal Stem Cells in a Rat Model of Parkinson Disease

  2011cites this paper
• Positive FP-CIT SPECT (DaTSCAN) in Clinical Alzheimer's Disease – An Unexpected Finding?

  2011cites this paper
• Zaburzenia perfuzji mózgowej ocenione metodą tomografii emisyjnej pojedynczego fotonu (SPECT) u pacjentów z otępieniem z ciałami Lewy'ego, chorobą Parkinsona oraz chorobą Alzheimera

  2009cites this paper
• Dopamine transporter single photon emission computerized tomography in the diagnosis of dementia with Lewy bodies

  2009cites this paper
• The 18F-FDG PET Cingulate Island Sign and Comparison to 123I-β-CIT SPECT for Diagnosis of Dementia with Lewy Bodies

  2009cites this paper
• Imaging of the dopaminergic system in differential diagnosis of dementia

  2008cites this paper
• Intérêt de la scintigraphie des transporteurs de la dopamine en gériatrie

  2008cites this paper
• A comparison of 99mTc-exametazime and 123I-FP-CIT SPECT imaging in the differential diagnosis of Alzheimer's disease and dementia with Lewy bodies

  2008cites this paper
• Imagerie moléculaire dans les démences

  2007cites this paper
• Imaging in dementia with Lewy bodies: a review

  2007cites this paper
• Neurorehabilitation in dementia on the move : Influences of physical activity on cognition, mood, and the rest-activity rhythm

  2007influential citation
• Mise au point Imagerie moléculaire dans les démences Molecular imaging of dementia

  2007cites this paper
• Limitations of the HMPAO SPECT appearances of occipital lobe perfusion in the differential diagnosis of dementia with Lewy bodies

  2007cites this paper
• Comparaison des performances de l’imagerie des transporteurs dopaminergiques et de la tomoscintigraphie de perfusion cérébrale à l’HMPAO-99mTc dans le diagnostic de maladie à corps de Lewy diffus

  2007cites this paper
• [The neurochemistry and neuropharmacology of diffuse Lewy body disease].

  2006cites this paper
• Perfusion Imaging with Single Photon Emission Computed Tomography

  2006cites this paper
• Imaging the dopaminergic system in suspected parkinsonism, drug induced movement disorders, and Lewy body dementia

  2005cites this paper
• Presynaptic nigro-striatal function in a group of Alzheimer’s disease patients with parkinsonism: evidence from a dopamine transporter imaging study

  2004cites this paper